8.66
price up icon1.88%   0.16
after-market Dopo l'orario di chiusura: 8.49 -0.17 -1.96%
loading

Kalaris Therapeutics Inc Borsa (KLRS) Ultime notizie

pulisher
Dec 10, 2025

Kalaris Therapeutics Inc. $KLRS Shares Sold by Gilead Sciences Inc. - MarketBeat

Dec 10, 2025
pulisher
Dec 05, 2025

Is Kalaris Therapeutics Inc. stock a good choice for value investorsEarnings Beat & Verified High Yield Trade Plans - Newser

Dec 05, 2025
pulisher
Dec 02, 2025

Kalaris Therapeutics (KLRS) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives $11.50 Consensus Target Price from Brokerages - Defense World

Dec 01, 2025
pulisher
Nov 30, 2025

Kalaris Therapeutics Inc Stock Analysis and ForecastGeopolitical Risk Analysis & Plan Your Future With Strategic Investing - earlytimes.in

Nov 30, 2025
pulisher
Nov 29, 2025

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

We Think Kalaris Therapeutics (NASDAQ:KLRS) Needs To Drive Business Growth Carefully - Yahoo Finance

Nov 27, 2025
pulisher
Nov 24, 2025

What analysts say about Kalaris Therapeutics Inc stockCandlestick Pattern Analysis & Rapid Capital Growth - earlytimes.in

Nov 24, 2025
pulisher
Nov 24, 2025

Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference - The Globe and Mail

Nov 24, 2025
pulisher
Nov 24, 2025

Kalaris (Nasdaq: KLRS) to present at Noble Capital 21st Emerging Growth Conference - Stock Titan

Nov 24, 2025
pulisher
Nov 23, 2025

Kalaris Therapeutics, Inc. (KLRS) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 23, 2025
pulisher
Nov 21, 2025

Kalaris Therapeutics Inc. (KLRS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

What risks investors should watch in Kalaris Therapeutics Inc. stockJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Equities Analysts Offer Predictions for KLRS Q4 Earnings - Defense World

Nov 21, 2025
pulisher
Nov 21, 2025

Leerink Partnrs Issues Pessimistic Outlook for KLRS Earnings - MarketBeat

Nov 21, 2025
pulisher
Nov 20, 2025

Kalaris Therapeutics (NASDAQ:KLRS) Is In A Good Position To Deliver On Growth Plans - Sahm

Nov 20, 2025
pulisher
Nov 20, 2025

What’s next for Kalaris Therapeutics Inc. stock priceTrade Exit Summary & Trade Opportunity Analysis - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Kalaris Therapeutics Inc. stock benefit from commodity pricesLong Setup & Daily Volume Surge Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What MACD and RSI say about Kalaris Therapeutics Inc.2025 Trading Recap & Risk Controlled Stock Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Kalaris Therapeutics Inc. stock deliver surprise earnings beat - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Kalaris Therapeutics Inc. rally from current levelsMarket Growth Summary & Stepwise Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Kalaris stock rating reiterated at Strong Buy by Raymond James - Investing.com Canada

Nov 18, 2025
pulisher
Nov 18, 2025

Kalaris Therapeutics Reports Q3 2025 Financial Progress - MSN

Nov 18, 2025
pulisher
Nov 17, 2025

How to use a screener to detect Kalaris Therapeutics Inc. breakoutsWeekly Investment Report & Verified Momentum Watchlists - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Kalaris Therapeutics (KLRS) Price Target Increased by 10.87% to 17.34 - Nasdaq

Nov 17, 2025
pulisher
Nov 16, 2025

Analyzing Kalaris Therapeutics Inc. with risk reward ratio charts2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Applying sector rotation models to Kalaris Therapeutics Inc.Oil Prices & Technical Confirmation Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

What to expect from Kalaris Therapeutics Inc. in the next 30 daysMarket Performance Summary & Consistent Profit Trading Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Does Kalaris Therapeutics Inc. qualify in momentum factor screeningMarket Rally & AI Driven Price Predictions - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

What is William Blair's Estimate for KLRS FY2025 Earnings? - MarketBeat

Nov 15, 2025
pulisher
Nov 15, 2025

William Blair Has Negative Estimate for KLRS FY2025 Earnings - Defense World

Nov 15, 2025
$38.38
price down icon 0.39%
$97.03
price down icon 1.63%
$31.35
price down icon 0.70%
$92.23
price down icon 1.68%
biotechnology ONC
$304.31
price down icon 2.05%
$200.67
price up icon 1.90%
Capitalizzazione:     |  Volume (24 ore):